Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNABW) Long-Term Investments (2021 - 2023)

Historic Long-Term Investments for Ginkgo Bioworks Holdings (DNABW) over the last 3 years, with Q4 2023 value amounting to $78.6 million.

  • Ginkgo Bioworks Holdings' Long-Term Investments fell 2997.02% to $78.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $78.6 million, marking a year-over-year decrease of 2997.02%. This contributed to the annual value of $78.6 million for FY2023, which is 2997.02% down from last year.
  • Ginkgo Bioworks Holdings' Long-Term Investments amounted to $78.6 million in Q4 2023, which was down 2997.02% from $85.0 million recorded in Q3 2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Long-Term Investments ranged from a high of $1.7 billion in Q1 2021 and a low of $78.6 million during Q4 2023
  • In the last 3 years, Ginkgo Bioworks Holdings' Long-Term Investments had a median value of $103.9 million in 2021 and averaged $371.9 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Long-Term Investments crashed by 9483.67% in 2022 and then skyrocketed by 3466.56% in 2023.
  • Over the past 3 years, Ginkgo Bioworks Holdings' Long-Term Investments (Quarter) stood at $102.0 million in 2021, then rose by 9.95% to $112.2 million in 2022, then dropped by 29.97% to $78.6 million in 2023.
  • Its last three reported values are $78.6 million in Q4 2023, $85.0 million for Q3 2023, and $119.9 million during Q2 2023.